The stock of Pulmonx Corporation (LUNG) closed the recent trading session at $26.25, losing 2.56% from the previous trading session. The company declared the financial results for Q4 and fiscal year 2021. Consequently, LUNG stock kept on following the bearish trend in the after-hours, losing 21.71% to $20.55. Pulmonx also filed for Form 8-K with the SEC on February 23, 2022.
Q4 2021 of LUNG
On 23 February 2022, LUNG declared the financial results for Q4 and year, which concluded on the 31st of December 2021. The salient points of the quarterly proceeds are
- The company posted $13.7 million in sales for Q4 of FY21 versus $9.8 million for Q4 of FY20. Recording an increase of 39.5% in sales.
- LUNG had a net loss of $13.0 million in the Q4 of FY21 as compared to $9.2 million in Q4 of 2020. The net loss increased by 39.8%.
- The Diluted loss of $0.35 per stock in Q4 of FY21 against $0.27 in Q4 of FY20.
- Moreover, the total expenses from operation for Q4 of 2021 was $22.6 million against $16.4 million in Q4 of 2020.
LUNG’s Full-year of 2021
The important points for the FY21 of LUNG are
- Gross sales of $48.4 million in 2021 versus $32.7 in 2022, expanding by 47.9% YoY.
- YoY net loss grew by 50.9% through $32.2 million in FY20 in comparison to $48.6 million in 2021.
- Besides, the Diluted loss of $1.35 per stock in FY21 against $3.16 in FY20.
- Furthermore, the cost from operations increased by 54.9% YoY. The cost in 2021 was $82.9 million versus $53.5 million in 2020.
Guidance for 2022
The sales for FY22 are anticipated to be between $55 million and $60 million YoY. Moreover, given the condition of the COVID-19 pandemic, LUNG anticipated the quarterly sales to be between $9 million and $10 million.
CEO Remarks
The CEO of Pulmonx, Glen French, commented that he is incredibly glad about their achievement in 2021. He further commented that they gained ground toward geographic venture into Japan and the clinical improvement of AeriSeal.
Moreover, Mr. French concluded that they anticipate expanding their solid establishment for the development in 2022.
